Ofer Mandelboim Selected Research

Ofer Mandelboim Research Topics

Disease

74	Neoplasms (Cancer) 11/2022 - 01/2004
27	Infections 01/2021 - 05/2006
9	Melanoma (Melanoma, Malignant) 11/2022 - 03/2002
8	Virus Diseases (Viral Diseases) 01/2022 - 06/2006
7	Human Influenza (Influenza) 12/2020 - 01/2004
6	Neoplasm Metastasis (Metastasis) 01/2018 - 12/2011
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2015 - 02/2010
3	Lymphoma (Lymphomas) 01/2018 - 02/2005
3	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 01/2014
2	Herpesviridae Infections (Herpesvirus Infection) 01/2021 - 01/2017
2	Hypersensitivity (Allergy) 01/2018 - 11/2013
2	Leukemia 06/2014 - 09/2003
1	Disease Progression 01/2022
1	Epstein-Barr Virus Infections 10/2021
1	Breast Neoplasms (Breast Cancer) 01/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Hypotension (Low Blood Pressure) 12/2018
1	Pulmonary Hypertension 12/2018
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2018
1	Mycoses (Diseases, Fungus) 11/2017
1	Zika Virus Infection 11/2017
1	Reoviridae Infections 10/2017
1	Adenocarcinoma 01/2017
1	Bacterial Infections (Bacterial Infection) 01/2017
1	Urinary Tract Infections (Urinary Tract Infection) 01/2017
1	HIV Infections (HIV Infection) 11/2016
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 10/2016
1	Renal Cell Carcinoma (Grawitz Tumor) 05/2016
1	Bacteremia 12/2015
1	Insulin Resistance 04/2015
1	Obesity 04/2015
1	Graft vs Host Disease (Graft-Versus-Host Disease) 06/2014
1	Hematologic Neoplasms (Hematological Malignancy) 06/2014
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2014

Drug/Important Bio-Agent (IBA)

39	LigandsIBA 01/2021 - 03/2002
21	Proteins (Proteins, Gene)FDA Link 12/2021 - 03/2002
15	Natural Cytotoxicity Triggering Receptor 1IBA 12/2020 - 04/2002
13	MicroRNAs (MicroRNA)IBA 01/2022 - 09/2008
9	CEACAM1 ProteinIBA 11/2022 - 03/2004
6	CytokinesIBA 10/2021 - 10/2009
6	micaIBA 01/2021 - 10/2014
6	Natural Killer Cell ReceptorsIBA 01/2017 - 05/2006
5	AntibodiesIBA 01/2020 - 01/2017
5	Viral HemagglutininsIBA 03/2016 - 01/2004
4	Monoclonal AntibodiesIBA 11/2022 - 01/2016
4	HLA-G Antigens (HLA G)IBA 01/2022 - 10/2014
4	Hemagglutinins (Hemagglutinin)IBA 12/2020 - 01/2004
4	AntigensIBA 10/2019 - 10/2006
4	InterferonsIBA 01/2018 - 04/2015
3	Immunoglobulin G (IgG)IBA 11/2022 - 05/2008
3	Carcinoembryonic AntigenIBA 01/2021 - 10/2007
3	NK Cell Lectin-Like Receptor Subfamily KIBA 01/2021 - 07/2007
3	Antiviral Agents (Antivirals)IBA 11/2017 - 12/2012
3	Histocompatibility Antigens Class IIBA 03/2013 - 08/2004
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2017
2	N-Acetylneuraminic Acid (Sialic Acid)IBA 12/2020 - 03/2016
2	VaccinesIBA 12/2020 - 01/2018
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2020 - 05/2016
2	LectinsIBA 01/2020 - 01/2017
2	Thomsen-Friedenreich antigenIBA 01/2020 - 01/2017
2	Pharmaceutical PreparationsIBA 01/2019 - 10/2003
2	Transcription Factors (Transcription Factor)IBA 12/2018 - 12/2014
2	Fibronectins (Fibronectin)IBA 01/2018 - 01/2018
2	Tumor Biomarkers (Tumor Markers)IBA 01/2016 - 06/2005
2	Glycoproteins (Glycoprotein)IBA 01/2016 - 04/2010
2	3' Untranslated Regions (3' UTR)IBA 12/2014 - 11/2012
2	Insulin (Novolin)FDA Link 01/2014 - 09/2011
2	Green Fluorescent ProteinsIBA 11/2013 - 05/2006
2	Polysaccharides (Glycans)IBA 04/2010 - 01/2008
1	Viral ProteinsIBA 12/2020
1	Peptides (Polypeptides)IBA 01/2020
1	Nelfinavir (Viracept)FDA Link 01/2020
1	Biological ProductsIBA 01/2020
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2020
1	HIV Protease InhibitorsIBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	Blocking AntibodiesIBA 01/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2019
1	poliovirus receptorIBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Angiopoietin-2IBA 12/2018
1	Interleukin-23 (Interleukin 23)IBA 12/2018
1	obinutuzumabIBA 01/2018
1	Extracellular Matrix ProteinsIBA 01/2018
1	Rituximab (Mabthera)FDA Link 01/2018
1	ofatumumab FDA Link 01/2018
1	ChromatinIBA 01/2018
1	Chemokine CXCL12IBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	Pathogen-Associated Molecular Pattern MoleculesIBA 10/2016
1	Viral RNAIBA 10/2016
1	ChemokinesIBA 11/2015
1	EnzymesIBA 02/2014

Therapy/Procedure

14	Therapeutics 01/2020 - 05/2008
6	Immunotherapy 01/2022 - 05/2014
2	Transplantation 11/2016 - 09/2003
1	Oncolytic Virotherapy 01/2019
1	Hematopoietic Stem Cell Transplantation 06/2014
1	Donor Selection 06/2014